Takeda announces acquisition of own shares

Osaka, japan--(business wire)--takeda pharmaceutical company limited (tokyo:4502/nyse:tak) (“takeda”) announced that its board of directors resolved today to engage in the acquisition of its own shares pursuant to the provision of its articles of incorporation in accordance with article 459, paragraph 1 of the companies act of japan, as detailed below. “at our current share price, we see an opportunity to buy back our shares at a substantial discount to what we perceive is their underlying valu
TAK Ratings Summary
TAK Quant Ranking